Involvement of substance P and the NK-1 receptor in cancer progression-Reference-Cited by-同舟云学术

Involvement of substance P and the NK-1 receptor in cancer progression

Published:2013-10 Issue: Volume:48 Page:1-9
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Muñoz Miguel,Coveñas Rafael

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference94 articles.

1. A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas;Akazawa;J Neurochem,2009

2. Efectos de los antagonistas de los receptores NK1 y de la dexametasona sobre la inflamación neurogénica inducida por ciclofosfamida y por radiación X, en la rata;Alfieri;AVFT,2004

3. Too many rodent carcinogens: mitogenesis increases mutagenesis;Ames;Science,1990

4. Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury;Bang;J Pharmacol Exp Ther,2003

5. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1;Bellucci;Br J Pharmacol,2002

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential function of microRNA miRNA-206 in breast cancer pathogenesis: Mechanistic aspects and clinical implications;Pathology - Research and Practice;2024-08

2. Combined neurokinin-1 receptor antagonist and sorafenib is a promising approach for hepatocellular carcinoma therapy;Egyptian Liver Journal;2024-07-12

3. Unveiling the Promising Role of Substance P/Neurokinin 1 Receptor in Cancer Cell Proliferation and Cell Cycle Regulation in Human Malignancies;Current Medicinal Chemistry;2024-07-10

4. Substance P – a regulatory peptide with defense and repair functions. Results and perspectives for the fight against COVID-19;Frontiers in Neurology;2024-05-30

5. Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells;Journal of Drug Targeting;2024-02